Contact Information
37 Westminster Buildings, Theatre Square,
Nottingham, NG1 6LG
We Are Available 24/ 7. Call Now.
CEO Lars Fruergaard Jorgensen discusses Wegovy
It’s been a rocky few months for Novo Nordisk. Prescription data from IQVIA suggests Novo’s obesity drug Wegovy is losing ground to rival Zepbound from
Eli Lilly to release data on weight loss drug retatrutide in 2025
The Eli Lilly & Co. logo at the company’s Digital Health Innovation Hub facility in Singapore, on Thursday, Nov. 14, 2024. Ore Huiying | Bloomberg
Eli Lilly (LLY) earnings Q4 2024
Eli Lilly on Thursday reported mixed results for the fourth quarter, even as demand for its blockbuster weight loss drug Zepbound and diabetes treatment Mounjaro